Page last updated: 2024-09-05

sorafenib and Breathlessness

sorafenib has been researched along with Breathlessness in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ando, Y; Bonichon, F; Brose, MS; Chung, J; Fassnacht, M; Fugazzola, L; Gao, M; Hadjieva, T; Hasegawa, Y; Kappeler, C; Meinhardt, G; Park, DJ; Schlumberger, M; Shi, Y; Shong, YK; Smit, JW; Worden, F	1
Chun, G; Dua, S; Hiensch, R; Meinhof, K; Nandedkar, D	1
Fujimoto, K; Gemma, A; Horiuchi-Yamamoto, Y; Inoue, Y; Johkoh, T; Kudoh, S; Sakai, F; Taniguchi, H	1

Trials

1 trial(s) available for sorafenib and Breathlessness

Article	Year
Safety and tolerability of sorafenib in patients with radioiodine-refractory thyroid cancer. Endocrine-related cancer, 2015, Volume: 22, Issue:6 Topics: Adenocarcinoma, Follicular; Adenoma, Oxyphilic; Aged; Antineoplastic Agents; Carcinoma, Papillary; Diarrhea; Disease-Free Survival; Drug Eruptions; Drug Resistance, Neoplasm; Dyspnea; Fatigue; Female; Humans; Hypertension; Hypocalcemia; Incidence; Iodine Radioisotopes; Male; Middle Aged; Neoplasms, Second Primary; Niacinamide; Phenylurea Compounds; Prevalence; Protein Kinase Inhibitors; Radiopharmaceuticals; Sorafenib; Thyroid Neoplasms; Weight Loss	2015

Article

Year

Safety and tolerability of sorafenib in patients with radioiodine-refractory thyroid cancer.

Endocrine-related cancer, 2015, Volume: 22, Issue:6

Topics: Adenocarcinoma, Follicular; Adenoma, Oxyphilic; Aged; Antineoplastic Agents; Carcinoma, Papillary; Diarrhea; Disease-Free Survival; Drug Eruptions; Drug Resistance, Neoplasm; Dyspnea; Fatigue; Female; Humans; Hypertension; Hypocalcemia; Incidence; Iodine Radioisotopes; Male; Middle Aged; Neoplasms, Second Primary; Niacinamide; Phenylurea Compounds; Prevalence; Protein Kinase Inhibitors; Radiopharmaceuticals; Sorafenib; Thyroid Neoplasms; Weight Loss

2015

Other Studies

2 other study(ies) available for sorafenib and Breathlessness

Article	Year
Early Radiation Toxicity from Yttrium-90 Radioembolization for Advanced Hepatocellular Carcinoma. American journal of respiratory and critical care medicine, 2016, Apr-01, Volume: 193, Issue:7 Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Carcinoma, Hepatocellular; Comorbidity; Dyspnea; Embolization, Therapeutic; Hepatitis B virus; Humans; Liver Cirrhosis; Liver Neoplasms; Lung Injury; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Prednisone; Radiation Exposure; Sorafenib; Ytterbium	2016
Drug-induced lung injury associated with sorafenib: analysis of all-patient post-marketing surveillance in Japan. International journal of clinical oncology, 2013, Volume: 18, Issue:4 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Cough; Dyspnea; Female; Fever; Humans; Japan; Liver Neoplasms; Lung; Male; Marketing; Middle Aged; Niacinamide; Phenylurea Compounds; Pulmonary Alveoli; Sorafenib	2013

Article

Year

Early Radiation Toxicity from Yttrium-90 Radioembolization for Advanced Hepatocellular Carcinoma.

American journal of respiratory and critical care medicine, 2016, Apr-01, Volume: 193, Issue:7

Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Carcinoma, Hepatocellular; Comorbidity; Dyspnea; Embolization, Therapeutic; Hepatitis B virus; Humans; Liver Cirrhosis; Liver Neoplasms; Lung Injury; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Prednisone; Radiation Exposure; Sorafenib; Ytterbium

2016

Drug-induced lung injury associated with sorafenib: analysis of all-patient post-marketing surveillance in Japan.

International journal of clinical oncology, 2013, Volume: 18, Issue:4

Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Cough; Dyspnea; Female; Fever; Humans; Japan; Liver Neoplasms; Lung; Male; Marketing; Middle Aged; Niacinamide; Phenylurea Compounds; Pulmonary Alveoli; Sorafenib

2013